Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Imdevimab is a monoclonal antibody engineered to neutralize viral particles by targeting unique epitopes on the viral spike protein. It works synergistically with other antibodies to enhance antiviral defense, making it a critical component in combination therapies. Imdevimab is especially effective against a broad range of virus strains, providing robust protection against variants.